Immunogen Announces C-code for Mirvetuximab Soravtansine-gynx

Elahare announced the new Healthcare Common Procedure Coding System (HCPCS) C-code for ElahereTM (mirvetuximab soravtansine-gynx), issued by the Centers for Medicare & Medicaid Services (CMS). The code C9146 is effective April 1, 2023 for mirvetuximab soravtansine-gynx injection of 1mg and may be used on claims billed under the hospital Outpatient Prospective Payment System.

For more information visit the Elahare website.

Posted 3/23/2023